$HR
Healthcare Realty Trust Inc

2010 Q4 Form 10-K Financial Statement

#000144530512000793 Filed on March 27, 2012

View on sec.gov

Income Statement

Concept 2010 Q4 2009 Q4 2009
Revenue $66.40M $60.20M $129.5M
YoY Change 10.3% 5.61% -37.26%
Cost Of Revenue $26.00M $23.70M $92.10M
YoY Change 9.7% 2.6% 15.56%
Gross Profit $40.30M $36.50M $150.7M
YoY Change 10.41% 7.67% 18.94%
Gross Profit Margin 60.69% 60.63% 116.38%
Selling, General & Admin $4.400M $5.200M $21.90M
YoY Change -15.38% -26.76% -11.69%
% of Gross Profit 10.92% 14.25% 14.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.40M $18.00M $70.90M
YoY Change 13.33% 24.14% 29.62%
% of Gross Profit 50.62% 49.32% 47.05%
Operating Expenses $23.50M $21.70M $87.00M
YoY Change 8.29% 3.33% 17.41%
Operating Profit $16.80M $14.80M -$1.198M
YoY Change 13.51% 14.73% -102.28%
Interest Expense -$17.30M -$13.10M -$39.40M
YoY Change 32.06% 61.73% -0.76%
% of Operating Profit -102.98% -88.51%
Other Income/Expense, Net $0.00 $0.00 $200.0K
YoY Change -60.0%
Pretax Income -$400.0K $1.700M $24.30M
YoY Change -123.53% -75.36% 58.82%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $400.0K $4.400M -$25.08M
YoY Change -90.91% -71.79% -160.14%
Net Earnings / Revenue 0.6% 7.31% -19.37%
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share $6.329K $74.32K -$0.22
COMMON SHARES
Basic Shares Outstanding 112.8M shares
Diluted Shares Outstanding 112.8M shares

Balance Sheet

Concept 2010 Q4 2009 Q4 2009
SHORT-TERM ASSETS
Cash & Short-Term Investments $113.3M $5.900M $5.900M
YoY Change 1820.34% 43.9% 43.9%
Cash & Equivalents $29.27M $219.0M $5.900M
Short-Term Investments
Other Short-Term Assets $24.70M
YoY Change 17.62%
Inventory
Prepaid Expenses
Receivables $16.00M $11.00M $5.300M
Other Receivables $0.00 $0.00 $25.20M
Total Short-Term Assets $113.3M $5.900M $61.10M
YoY Change 1820.34% 43.9% 10.49%
LONG-TERM ASSETS
Property, Plant & Equipment $2.087B $1.792B $1.792B
YoY Change 16.48% 9.62% 9.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.300M
YoY Change -53.57%
Other Assets $23.90M $17.70M $17.70M
YoY Change 35.03% -80.38% -80.38%
Total Long-Term Assets $2.158B $1.930B $1.875B
YoY Change 11.84% 3.72% 3.6%
TOTAL ASSETS
Total Short-Term Assets $113.3M $5.900M $61.10M
Total Long-Term Assets $2.158B $1.930B $1.875B
Total Assets $2.272B $1.936B $1.936B
YoY Change 17.36% 3.81% 3.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.70M $55.00M $55.00M
YoY Change 14.0% 19.83% 19.83%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $62.70M $55.00M $55.00M
YoY Change 14.0% 19.83% 19.83%
LONG-TERM LIABILITIES
Long-Term Debt $1.408B $1.046B $1.046B
YoY Change 34.55% 11.3% 11.3%
Other Long-Term Liabilities $44.10M $44.20M $44.20M
YoY Change -0.23% -46.36% -46.36%
Total Long-Term Liabilities $1.452B $1.091B $1.091B
YoY Change 33.14% 6.65% 6.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $62.70M $55.00M $55.00M
Total Long-Term Liabilities $1.452B $1.091B $1.091B
Total Liabilities $780.7M $1.149B $1.149B
YoY Change -32.06% 7.38% 7.38%
SHAREHOLDERS EQUITY
Retained Earnings -$310.2M
YoY Change
Common Stock $1.797B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.487B $1.071B $786.8M
YoY Change
Total Liabilities & Shareholders Equity $2.272B $1.936B $1.936B
YoY Change 17.36% 3.81% 3.81%

Cashflow Statement

Concept 2010 Q4 2009 Q4 2009
OPERATING ACTIVITIES
Net Income $400.0K $4.400M -$25.08M
YoY Change -90.91% -71.79% -160.14%
Depreciation, Depletion And Amortization $20.40M $18.00M $70.90M
YoY Change 13.33% 24.14% 29.62%
Cash From Operating Activities $18.80M $20.80M $21.63M
YoY Change -9.62% -23.53% -79.46%
INVESTING ACTIVITIES
Capital Expenditures -$131.3M -$71.20M -$170.5M
YoY Change 84.41% -70.96% -55.56%
Acquisitions
YoY Change
Other Investing Activities -$68.90M $2.500M $72.80M
YoY Change -2856.0% -139.06% 391.89%
Cash From Investing Activities -$200.2M -$68.80M -$455.1M
YoY Change 190.99% -72.67% 23.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$606.4M
YoY Change -407.81%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 283.7M 48.80M $524.1M
YoY Change 481.35% -78.16% 102.22%
NET CHANGE
Cash From Operating Activities 18.80M 20.80M $21.63M
Cash From Investing Activities -200.2M -68.80M -$455.1M
Cash From Financing Activities 283.7M 48.80M $524.1M
Net Change In Cash 102.3M 800.0K $90.67M
YoY Change 12687.5% -172.73% -2160.68%
FREE CASH FLOW
Cash From Operating Activities $18.80M $20.80M $21.63M
Capital Expenditures -$131.3M -$71.20M -$170.5M
Free Cash Flow $150.1M $92.00M $192.1M
YoY Change 63.15% -66.23% -60.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
43033000 USD
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
47801000 USD
CY2010Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1795413000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2032305000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
3221000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
1313000 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
816000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
18896000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
56621000 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
64793000 USD
CY2010 us-gaap Asset Management Fees
AssetManagementFees
0 USD
CY2009 us-gaap Asset Management Fees
AssetManagementFees
-3783000 USD
CY2011 us-gaap Asset Management Fees
AssetManagementFees
0 USD
CY2010Q4 us-gaap Assets
Assets
2271795000 USD
CY2011Q4 us-gaap Assets
Assets
2291629000 USD
CY2009 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
15997000 USD
CY2010 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11317000 USD
CY2011 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2130000 USD
CY2010 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2768000 USD
CY2011 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5448000 USD
CY2009 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1783000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29270000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69491000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219001000 USD
CY2008Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128331000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
40221000 USD
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-189731000 USD
CY2009 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
90670000 USD
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
202643705 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228491312 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228491312 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
202643705 shares
CY2010 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
2284000 USD
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
2026000 USD
CY2010 us-gaap Costs And Expenses
CostsAndExpenses
181578000 USD
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
227127000 USD
CY2009 us-gaap Costs And Expenses
CostsAndExpenses
130684000 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
107542000 USD
CY2010 us-gaap Depreciation And Amortization
DepreciationAndAmortization
78561000 USD
CY2009 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53595000 USD
CY2011Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1792000 USD
CY2010Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1527000 USD
CY2009 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
45024000 USD
CY2011 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
88760000 USD
CY2010 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
65662000 USD
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2009 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2009 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2010 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2010Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
304355000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
272390000 USD
CY2010 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-7285000 USD
CY2011 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2009 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28695000 USD
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18753000 USD
CY2009 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12285000 USD
CY2010 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3207000 USD
CY2009 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3332000 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5388000 USD
CY2011 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-14463000 USD
CY2010 us-gaap Income Taxes Paid
IncomeTaxesPaid
345000 USD
CY2009 us-gaap Income Taxes Paid
IncomeTaxesPaid
337000 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
1045000 USD
CY2011 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-2424000 USD
CY2009 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
5167000 USD
CY2010 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
7102000 USD
CY2009 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4856000 USD
CY2010 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7815000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
295000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 USD
CY2009 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
3631000 USD
CY2010 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-4776000 USD
CY2010 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
0 USD
CY2009 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
-6000 USD
CY2011 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
0 USD
CY2010 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2009 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2010 us-gaap Interest Paid
InterestPaid
30438000 USD
CY2011 us-gaap Interest Paid
InterestPaid
38288000 USD
CY2009 us-gaap Interest Paid
InterestPaid
27623000 USD
CY2010 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
119000 USD
CY2009 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
249000 USD
CY2011 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
174000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
720504000 USD
CY2010Q4 us-gaap Liabilities
Liabilities
780682000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2271795000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2291629000 USD
CY2010Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
7000000 USD
CY2011Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0 USD
CY2010 us-gaap Loans Assumed1
LoansAssumed1
190294000 USD
CY2009 us-gaap Loans Assumed1
LoansAssumed1
52965000 USD
CY2011 us-gaap Loans Assumed1
LoansAssumed1
6657000 USD
CY2010 us-gaap Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
-16000 USD
CY2011 us-gaap Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
52000 USD
CY2009 us-gaap Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
304000 USD
CY2011 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Description of Business</font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare Trust of America, Inc., a Maryland corporation, was incorporated on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;20, 2006</font><font style="font-family:inherit;font-size:10pt;">. We were initially capitalized on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;28, 2006</font><font style="font-family:inherit;font-size:10pt;"> and consider that to be our date of inception.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are a fully integrated, self-administered, and self-managed real estate investment trust, or REIT. Accordingly, our internal management team manages our day-to-day operations and oversees and supervises our employees and outside service providers. Acquisitions and asset management services are performed in-house by our employees, with certain monitored services provided by third parties at market rates. We do not pay acquisition, disposition, or asset management fees to an external advisor, and we have not and will not pay any internalization fees.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provide stockholders the potential for income and growth through investment in a diversified portfolio of real estate properties. We focus primarily on medical office buildings and other facilities that serve the healthcare industry. We also invest to a limited extent in other real estate-related assets, such as mortgage loans receivable. However, we do not presently intend to invest more than 15.0% of our total assets in such other real estate-related assets. We focus primarily on investments that produce recurring income. Subject to the discussion in Note&#160;11, Commitments and Contingencies, we believe that we have qualified to be taxed as a REIT for federal income tax purposes and we intend to continue to be taxed as a REIT. We conduct substantially all of our operations through Healthcare Trust of America Holdings, LP, or our operating partnership.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2011</font><font style="font-family:inherit;font-size:10pt;">, we had made </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">79</font><font style="font-family:inherit;font-size:10pt;"> portfolio acquisitions, which includes 248 buildings and two mortgage loans receivable. The aggregate purchase price of these acquisitions was $2,334,673,000. </font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;20, 2006</font><font style="font-family:inherit;font-size:10pt;">, we commenced a best efforts initial public offering, or our initial offering, in which we offered up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">200,000,000</font><font style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21,052,632</font><font style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share, aggregating up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,200,000,000</font><font style="font-family:inherit;font-size:10pt;">. On </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;19, 2010</font><font style="font-family:inherit;font-size:10pt;">, we commenced a best efforts follow-on public offering, or our follow-on offering, in which we offered up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">200,000,000</font><font style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in our primary offering and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21,052,632</font><font style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock pursuant to the DRIP at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share, aggregating up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,200,000,000</font><font style="font-family:inherit;font-size:10pt;">. We stopped offering shares in the primary offering on February 28, 2011. We continue to offer shares pursuant to the DRIP; however, we may terminate the DRIP at any time. In aggregate, we received and accepted subscriptions in our initial and follow-on offerings for 220,673,545 shares of our common stock, or $2,195,655,000, excluding shares of our common stock issued under the DRIP.</font></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our principal executive offices are located 16435 N. Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254. Our telephone number is (480) 998-3478. For investor services, contact DST Systems, Inc. by telephone at (888) 801-0107.</font></div></div>
CY2009 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
524147000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5628000 USD
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
378615000 USD
CY2009 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-455105000 USD
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-626849000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65958000 USD
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58503000 USD
CY2009 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21628000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111807000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
5541000 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-7903000 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-25077000 USD
CY2011Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
639149000 USD
CY2010Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
699526000 USD
CY2010Q4 us-gaap Notes Receivable Net
NotesReceivableNet
57091000 USD
CY2011Q4 us-gaap Notes Receivable Net
NotesReceivableNet
57459000 USD
CY2010Q4 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
13428000 USD
CY2011Q4 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
11832000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
47311000 USD
CY2009 us-gaap Operating Income Loss
OperatingIncomeLoss
-1198000 USD
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
21503000 USD
CY2011Q4 us-gaap Other Assets
OtherAssets
56442000 USD
CY2010Q4 us-gaap Other Assets
OtherAssets
40552000 USD
CY2011Q4 us-gaap Other Liabilities
OtherLiabilities
19930000 USD
CY2010Q4 us-gaap Other Liabilities
OtherLiabilities
16168000 USD
CY2011Q4 us-gaap Other Restricted Assets
OtherRestrictedAssets
16718000 USD
CY2010Q4 us-gaap Other Restricted Assets
OtherRestrictedAssets
26679000 USD
CY2009 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16266000 USD
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
37680000 USD
CY2010 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
51856000 USD
CY2011 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3401000 USD
CY2010 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7507000 USD
CY2009 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
792000 USD
CY2010 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
60176000 USD
CY2009 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39500000 USD
CY2011 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
84800000 USD
CY2010Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
3867000 USD
CY2011Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
3785000 USD
CY2011 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7000000 USD
CY2009 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2011 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
264000 USD
CY2009 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
379000 USD
CY2010 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
164000 USD
CY2011 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
21137000 USD
CY2010 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
56621000 USD
CY2009 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
68360000 USD
CY2011 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
0 USD
CY2010 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
4097000 USD
CY2009 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
0 USD
CY2009 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
37135000 USD
CY2010 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
0 USD
CY2011 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
0 USD
CY2010 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14888000 USD
CY2011 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16034000 USD
CY2009 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9060000 USD
CY2009 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
402268000 USD
CY2011 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
61385000 USD
CY2010 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
597097000 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0.00 shares
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0.00 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0.00 shares
CY2010Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0.00 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2009 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
481000 USD
CY2010 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2009 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
622652000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
214641000 USD
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
594677000 USD
CY2009 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
37696000 USD
CY2011 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
125500000 USD
CY2010 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
79125000 USD
CY2010 us-gaap Profit Loss
ProfitLoss
-7919000 USD
CY2011 us-gaap Profit Loss
ProfitLoss
5593000 USD
CY2009 us-gaap Profit Loss
ProfitLoss
-24773000 USD
CY2011 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1447000 USD
CY2009 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
965000 USD
CY2010 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1022000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-467249000 USD
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-310193000 USD
CY2010 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-7000000 USD
CY2009 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
11671000 USD
CY2011 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
192083000 USD
CY2011Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1806471000 USD
CY2010Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1797463000 USD
CY2009 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
126333000 USD
CY2011 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
269646000 USD
CY2010 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
195496000 USD
CY2011 us-gaap Revenues
Revenues
274438000 USD
CY2009 us-gaap Revenues
Revenues
129486000 USD
CY2010 us-gaap Revenues
Revenues
203081000 USD
CY2010 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
123117000 USD
CY2009 us-gaap Share Based Compensation
ShareBasedCompensation
816000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
3221000 USD
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
1313000 USD
CY2011 us-gaap Stock Issued1
StockIssued1
75864000 USD
CY2010 us-gaap Stock Issued1
StockIssued1
56551000 USD
CY2009 us-gaap Stock Issued1
StockIssued1
38559000 USD
CY2010 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
56551000 USD
CY2009 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
38559000 USD
CY2011 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
75864000 USD
CY2009 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
622652000 USD
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
594677000 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
214641000 USD
CY2011 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
37680000 USD
CY2009 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
16266000 USD
CY2010 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
51856000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
1487246000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1567340000 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
1071317000 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
599320000 USD
CY2009 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5523000 USD
CY2011 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-856000 USD
CY2010 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
6095000 USD
CY2010 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165952860 shares
CY2009 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112819638 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
224391553 shares
CY2010 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165952860 shares
CY2009 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112819638 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
223900167 shares
CY2010Q4 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
16385000 USD
CY2011Q4 hta Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
12658000 USD
CY2011 hta Acquisition Costs Related To Mortgage Notes Receivable
AcquisitionCostsRelatedToMortgageNotesReceivable
0 USD
CY2009 hta Acquisition Costs Related To Mortgage Notes Receivable
AcquisitionCostsRelatedToMortgageNotesReceivable
555000 USD
CY2010 hta Acquisition Costs Related To Mortgage Notes Receivable
AcquisitionCostsRelatedToMortgageNotesReceivable
0 USD
CY2009 hta Derivative Financial Instruments Termination Payments
DerivativeFinancialInstrumentsTerminationPayments
0 USD
CY2011 hta Adjustment To Redeemable Noncontrolling Interests Financing Activities
AdjustmentToRedeemableNoncontrollingInterestsFinancingActivities
0 USD
CY2010 hta Adjustment To Redeemable Noncontrolling Interests Financing Activities
AdjustmentToRedeemableNoncontrollingInterestsFinancingActivities
-275000 USD
CY2009 hta Adjustment To Redeemable Noncontrolling Interests Financing Activities
AdjustmentToRedeemableNoncontrollingInterestsFinancingActivities
1673000 USD
CY2010 hta Adjustments To Redeemable Noncontrolling Interest
AdjustmentsToRedeemableNoncontrollingInterest
275000 USD
CY2009 hta Adjustments To Redeemable Noncontrolling Interest
AdjustmentsToRedeemableNoncontrollingInterest
-1673000 USD
CY2011 hta Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
104045000 USD
CY2010 hta Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
72678000 USD
CY2009 hta Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
48808000 USD
CY2011 hta Derivative Financial Instruments Termination Payments
DerivativeFinancialInstrumentsTerminationPayments
0 USD
CY2010 hta Derivative Financial Instruments Termination Payments
DerivativeFinancialInstrumentsTerminationPayments
793000 USD
CY2010 hta Distributions
Distributions
120507000 USD
CY2009 hta Distributions
Distributions
82221000 USD
CY2011 hta Distributions
Distributions
162597000 USD
CY2009 hta Distributions Declared But Not Paid Including Stock Issued Under Drip
DistributionsDeclaredButNotPaidIncludingStockIssuedUnderDrip
8555000 USD
CY2011 hta Distributions Declared But Not Paid Including Stock Issued Under Drip
DistributionsDeclaredButNotPaidIncludingStockIssuedUnderDrip
14120000 USD
CY2010 hta Distributions Declared But Not Paid Including Stock Issued Under Drip
DistributionsDeclaredButNotPaidIncludingStockIssuedUnderDrip
12317000 USD
CY2011 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
-686000 USD
CY2010 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
4774000 USD
CY2009 hta Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
1341000 USD
CY2010 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
2816000 USD
CY2009 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
4678000 USD
CY2011 hta Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
2279000 USD
CY2009 hta Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
19146000 USD
CY2010 hta Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
26725000 USD
CY2011 hta Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
39613000 USD
CY2011 hta Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
4792000 USD
CY2010 hta Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
7585000 USD
CY2009 hta Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
3153000 USD
CY2010 hta Issuance Of Operating Partnership Units In Connection With Company
IssuanceOfOperatingPartnershipUnitsInConnectionWithCompany
1557000 USD
CY2009 hta Issuance Of Operating Partnership Units In Connection With Company
IssuanceOfOperatingPartnershipUnitsInConnectionWithCompany
0 USD
CY2011 hta Issuance Of Operating Partnership Units In Connection With Company
IssuanceOfOperatingPartnershipUnitsInConnectionWithCompany
0 USD
CY2009 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
767000 USD
CY2011 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
596000 USD
CY2010 hta Proceeds From Security Deposits
ProceedsFromSecurityDeposits
2144000 USD
CY2010 hta Real Estate Deposits
RealEstateDeposits
2250000 USD
CY2011 hta Real Estate Deposits
RealEstateDeposits
0 USD
CY2009 hta Real Estate Deposits
RealEstateDeposits
250000 USD
CY2011 hta Real Estate Deposits Paid
RealEstateDepositsPaid
4500000 USD
CY2010 hta Real Estate Deposits Paid
RealEstateDepositsPaid
0 USD
CY2009 hta Real Estate Deposits Paid
RealEstateDepositsPaid
0 USD
CY2011 hta Real Estate Deposits Used
RealEstateDepositsUsed
6000000 USD
CY2010 hta Real Estate Deposits Used
RealEstateDepositsUsed
0 USD
CY2009 hta Real Estate Deposits Used
RealEstateDepositsUsed
0 USD
CY2011 hta Restricted Cash And Escrow Deposits
RestrictedCashAndEscrowDeposits
4502000 USD
CY2010 hta Restricted Cash And Escrow Deposits
RestrictedCashAndEscrowDeposits
12614000 USD
CY2009 hta Restricted Cash And Escrow Deposits
RestrictedCashAndEscrowDeposits
6318000 USD
CY2010 hta Security Deposits Prepaid Rent And Other Liabilities
SecurityDepositsPrepaidRentAndOtherLiabilities
14552000 USD
CY2009 hta Security Deposits Prepaid Rent And Other Liabilities
SecurityDepositsPrepaidRentAndOtherLiabilities
0 USD
CY2011 hta Security Deposits Prepaid Rent And Other Liabilities
SecurityDepositsPrepaidRentAndOtherLiabilities
0 USD
CY2011 dei Amendment Flag
AmendmentFlag
false
CY2011 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2011 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2011 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
CY2011 dei Document Period End Date
DocumentPeriodEndDate
2011-12-31
CY2011 dei Document Type
DocumentType
10-K
CY2011 dei Entity Central Index Key
EntityCentralIndexKey
0001360604
CY2012Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
229502006 shares
CY2011 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2011 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2011Q2 dei Entity Public Float
EntityPublicFloat
1624601000 USD
CY2011 dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE TRUST OF AMERICA, INC.
CY2011 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2011 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001445305-12-000793-index-headers.html Edgar Link pending
0001445305-12-000793-index.html Edgar Link pending
0001445305-12-000793.txt Edgar Link pending
0001445305-12-000793-xbrl.zip Edgar Link pending
buildinginfograph.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
hta-20111231.xml Edgar Link completed
hta-20111231.xsd Edgar Link pending
hta-20111231_cal.xml Edgar Link unprocessable
hta-20111231_def.xml Edgar Link unprocessable
hta-20111231_lab.xml Edgar Link unprocessable
hta-20111231_pre.xml Edgar Link unprocessable
hta2011123110-k.htm Edgar Link pending
hta2011123110k02.gif Edgar Link pending
htaex211_2011123110-k.htm Edgar Link pending
htaex231_2011123110-k.htm Edgar Link pending
htaex311_2011123110-k.htm Edgar Link pending
htaex312_2011123110-k.htm Edgar Link pending
htaex321_2011123110-k.htm Edgar Link pending
htaex322_2011123110-k.htm Edgar Link pending
item1statepresencechart.jpg Edgar Link pending
nationalhealthcareexpchart4.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
top20tenants3.jpg Edgar Link pending